Contents 4 dk okuma
What is Pramiracetam?
Pramiracetam is a fat-soluble synthetic racetam developed by Parke-Davis in the late 1970s and obtained by adding a diisopropylaminoethyl side chain to the piracetam backbone. This molecule, whose chemical name is N-[2-(diisopropylamino)ethyl]-2-oxo-1-pyrrolidinacetamide, is among the compounds with the highest molar potential of the racetam family.
While the majority of other racetams are water soluble, pramiracetam is fat soluble Its structure facilitates its passage through the brain membranes and increases its bioavailability. This feature is the main pharmacokinetic advantage that distinguishes pramiracetam from other racetams in terms of dose efficiency.
Its Place in the Racetam Family
Its place in the Racetam family: Piracetam is a balanced and mild starting molecule; oxiracetam is focused on speed and logic; aniracetam creativity and anxiolytic tendencies; Pramiracetam, on the other hand, is positioned as a high-potential, memory and focus-oriented molecule. Since it is fat soluble, taking it with a fatty meal optimizes bioavailability.
Mechanism of Effect
The cognitive effects of pramiracetam are explained primarily through two complementary mechanisms:
1. High Affinity Choline Uptake (HACU)
The best documented effect of pramiracetam is an increase in high-affinity choline uptake (High-Affinity Choline Uptake - HACU) in the hippocampus. HACU is the transport system that allows nerve terminals to actively take up choline for acetylcholine synthesis. Increasing the capacity of this system allows cholinergic neurons to produce more acetylcholine, strengthening memory and learning processes.
2. Nitric Oxide Pathway and Cerebral Blood Flow
Some studies report that pramiracetam has a positive effect on nitric oxide synthase (NOS) activity. Increased nitric oxide production by regulating cerebral vascular tone blood flow to brain areas can increase; this mechanism has been particularly studied in traumatic brain injury (TBI) models.
3. Neuronal Membrane Fluidity
Like other racetams, pramiracetam improves ion channel function and receptor sensitivity by affecting neuronal membrane fluidity and phosphatidylserine metabolism. This effect is a mechanism thought to contribute to long-term potentiation (LTP).
Clinical Evidence
Studies on Pramiracetam were conducted predominantly in the 1980s and 1990s in age-related memory impairment, dementia, and traumatic brain injury (TBI) populations. These studies reported significant improvements in memory tests and cognitive function measures compared to placebo.
A group of studies conducted specifically in the context of TBI indicates that pramiracetam may contribute to the recovery of memory losses. However, samples are small, method quality varies, and the majority of studies are limited to clinical populations; High-quality evidence for use for cognitive enhancement in healthy young individuals is limited.
⚠ Limitation of Evidence
Limitation of evidence: Modern, high-quality randomized controlled studies showing the effectiveness of pramiracetam in healthy individuals are very few. Available clinical data are predominantly from populations with cognitive impairment. Therefore, expectations should be kept cautious when used as a cognitive enhancer.
Dosage and Usage Protocol
| target | Daily Dose | How to Use | Note |
|---|---|---|---|
| Start (tolerance test) | 400 mg/day | Single dose, morning | First 1–2 weeks |
| cognitive support | 600–800 mg/day | 2× divided dose | Most common range |
| high dose | 1200 mg/day | 2–3× divided dose | Choline supplement is mandatory |
Since Pramiracetam is fat soluble with a fatty food Taking it (butter, olive oil, eggs, etc.) significantly increases its bioavailability. Since its half-life is 5–7 hours, two daily doses are suitable for most users; It is recommended to avoid taking it late in the evening.
- Alpha-GPC: 300–600 mg/day - High blood-brain barrier permeability; supports the HACU mechanism by making choline readily available (preferred option)
- CDP-Choline (Citicoline): 250–500 mg/day - Adds dopaminergic synergy; May reinforce memory effects
Safety and Side Effects
Pramiracetam has been evaluated as a low-toxicity compound that is generally well tolerated in available clinical studies. Reported side effects are mild and temporary.
| Possible Impact | frequency | Management |
|---|---|---|
| headache | Common (in choline deficiency) | Add choline source |
| Irritability/restlessness | rare | Reduce dose; avoid evening use |
| stomach upset | rare | Take with fatty food |
⚠ Legal Status
Legal status: Pramiracetam is not licensed as a food supplement in many countries, including Türkiye, and is in a regulatory gray area. The legal status of raw material forms sourced abroad is unclear. It is recommended that you consult current legislation and a physician's opinion before use. This content does not constitute medical advice.
Is Pramiracetam Legal in Türkiye?
Pramiracetam is not licensed as a food supplement in Türkiye and is not included as standard in the pharmacy prescription drug catalogue. Foreign sourced raw material forms are in a legally uncertain area. It is recommended that those considering using it consult a neurologist or physician.
Sources
- Malykh, A.G., Sadaie, M.R. (2010). Piracetam and piracetam-like drugs: from basic science to novel clinical applications. Drugs, 70(3), 287–312. Search PubMed (match unverified)
- Gouliaev, A.H., Senning, A. (1994). Piracetam and other structurally related nootropics. Brain Research Reviews, 19(2), 180–222. PubMed · PMID 8061686
- Mondadori, C. et al. (1992). Pramiracetam: a better memory enhancer than piracetam? Psychopharmacology, 106(Suppl), S130–S132. Search PubMed (match unverified)
- Bhattacharya, S.K. et al. (1993). Pramiracetam (CI-879) attenuates learned helplessness in rats. Pharmacology Biochemistry and Behavior, 45(4), 915–920. Search PubMed (match unverified)
Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory
Frequently Asked Questions
Pramiracetam is a fat-soluble synthetic nootropic that is one of the most potent members of the racetam family. It supports acetylcholine synthesis by increasing high-affinity choline uptake (HACU) in the hippocampus; Its effects on memory consolidation, focus, and cerebral blood flow have been studied in clinical contexts.
The common range of use is 400–1200 mg per day, usually in 2 divided doses. It is considered essential to take it with a choline source such as Alpha-GPC (300–600 mg/day) or CDP-Choline, as it significantly increases choline utilization; Otherwise, the risk of headache increases.
Pramiracetam, unlike many other racetams, is a fat-soluble molecule. Taking it with a meal containing fat, such as butter, olive oil or eggs, significantly increases its absorption from the intestine and therefore its bioavailability.
Pramiracetam has much higher potency than piracetam and works at lower doses. Its fat-soluble structure is different from piracetam. Both require cholinergic synergy; however, the effect of pramiracetam on HACU has been more clearly documented.
Pramiracetam is not available as a food supplement or licensed medicine in Türkiye; Its legal status remains in the gray area. It is recommended to consult current legislation and a healthcare professional before use.
